Tryptophan for urinary symptoms from prostate enlargement
Treatments studied
Part of Kidney & urinary clinical trials.
This Phase 2 study tests whether tryptophan is safe and can improve urinary symptoms caused by an enlarged prostate (BPH). It focuses on men who have bothersome, stable symptoms and who would normally take tamsulosin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign consent and follow study instructions
- You are a man age 50 to under 75 with BPH and your doctor says tamsulosin is appropriate
- Your prostate size is at least 30 cubic centimeters (measured on an ultrasound called TRUS)
- Your urinary symptoms (IPSS score) are 13 or higher and stable
- You do not have signs of urine blockage other than BPH, and your leftover urine after peeing is under 250 mL
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking Tamsulosin before a prostate biopsy can help prevent short-term urination problems. It may be a good option if you are scheduled for a biopsy and haven't taken similar drugs recently.
This study tests whether taking tadalafil (at 2.5 mg or 5 mg) along with tamsulosin is better for treating urinary symptoms caused by an enlarged prostate than taking tamsulosin alone. It aims to find the best dose combination to improve your quality of life.
This trial tests a drug called Tranilast to see if it can improve urinary symptoms caused by an enlarged prostate. It focuses on men with moderate to severe symptoms and a prostate size greater than 40 mL.
This trial compares two medications, silodosin and tamsulosin, to see which one works better for men with frequent or difficult urination caused by an enlarged prostate. All participants will try both medicines at different times to find the best option.
This study is for men with moderate to severe BPH symptoms who haven't responded well to one medicine alone. It tests a combination of two drugs (solifenacin and tamsulosin) to see if they improve symptom control and quality of life.
This trial tests new treatment strategies for benign prostatic hyperplasia (BPH, an enlarged prostate) using a special MRI scan and a medication called finasteride. It aims to find better ways to manage symptoms and identify markers that predict response.
Hear when a new BPH trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.